Alnajashi, H. (2025) “Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment”, Journal of Contemporary Medical Sciences, 11(4). doi: 10.22317/jcms.v11i4.1916.